Argent Biopharma Limited has released a press release.
Additional Information on Ground-breaking Research
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Argent Biopharma
- MGC Research- Effectiveness of Cannabinoids on Brain Cancers
- Germany, Austria & Switzerland Distribution Agreement Signed
- Brazil Distribution Agreement signed for MGC Pharma Products
- Pharma Update - Increased Orders and Clinical Study
- Material Revenues Confirmed from Non-Pharma Business Units
Later from Argent Biopharma
- MGC Signs Agreement for Construction of GMP Pharma Facility
- MXC 100 Patient Milestone in Aus, Onboards Tetra Health
- Canaccord to Lead LSE Listing and $4.75m Placement Closed
- Trial on the Effect of CannEpil on Driver Competency
- Approval Granted for Large-Scale Research Project with IHPS
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma